BG45 acts as an HDAC class I inhibitor with selectvity for HDAC3. HDACs represent novel targets for anti-tumer drugs treating various cancers including multiple myeloma cancer.
Molecular Formula:C11H10N4O
Solubility:DMSO (Slightly), Methanol (Slightly)
Molecular Weight:214.22
Storage and Stability:Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.